[{"id":"a936a984-a433-4d2f-9076-818499dfb605","acronym":"","url":"https://clinicaltrials.gov/study/NCT02317471","created_at":"2022-06-02T08:58:27.981Z","updated_at":"2024-07-02T16:37:31.505Z","phase":"Phase 1/2","brief_title":"Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96","source_id_and_acronym":"NCT02317471","lead_sponsor":"Chinese PLA General Hospital","biomarkers":" IFNG","pipe":"","alterations":" ","tags":["IFNG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • oxaliplatin • Teysuno (gimeracil/oteracil/tegafur) • Rebys (HSP Gp96 vaccine)"],"overall_status":"Unknown status","enrollment":" Enrollment 45","initiation":"Initiation: 11/01/2014","start_date":" 11/01/2014","primary_txt":" Primary completion: 12/01/2017","primary_completion_date":" 12/01/2017","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2016-06-06"}]